Literature DB >> 8604699

High incidence of common bile duct dilatation in autosomal dominant polycystic kidney disease patients.

I Ishikawa1, E Chikamoto, M Nakamura, M Asaka, N Tomosugi, T Yuri.   

Abstract

Two autosomal dominant kidney disease (ADPKD) patients with cholecystitis or communicating extrahepatic dilatation of the common bile duct accompanied by tiny common bile duct stones prompted us to examine the incidence of gall stone disease and dilatation of the common bile duct in ADPKD patients. Computed tomography scans were examined retrospectively in 55 ADPKD patients and 55 age-, gender-, and duration of dialysis-matched non-ADPKD patients. The incidence of calcium-containing gall stones found on tomography scans was the same: eight of the 55 ADPKD patients and nine of the 55 non-ADPKD patients. However, common bile duct dilatation, defined as measuring more than 7 mm in diameter at the pancreatic head on CT scans, was found more frequently in the ADPKD patients (22 patients; 40.0%) than in the non-ADPKD patients (5 patients; 9.1%) (P = 0.0002). These results suggest that the high incidence of intrapancreatic common bile duct dilatation in ADPKD is a previously undescribed sign of extracellular matrix remodeling in ADPKD.

Entities:  

Mesh:

Year:  1996        PMID: 8604699     DOI: 10.1016/s0272-6386(96)90353-4

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

Review 1.  Jaundice in Polycystic Liver Disease: More Than Meets the Eye.

Authors:  Danielle Brandman
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

2.  Liver involvement in early autosomal-dominant polycystic kidney disease.

Authors:  Marie C Hogan; Kaleab Abebe; Vicente E Torres; Arlene B Chapman; Kyongtae T Bae; Cheng Tao; Hongliang Sun; Ronald D Perrone; Theodore I Steinman; William Braun; Franz T Winklhofer; Dana C Miskulin; Frederic Rahbari-Oskoui; Godela Brosnahan; Amirali Masoumi; Irina O Karpov; Susan Spillane; Michael Flessner; Charity G Moore; Robert W Schrier
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-09       Impact factor: 11.382

Review 3.  Polycystic kidney disease.

Authors:  Carsten Bergmann; Lisa M Guay-Woodford; Peter C Harris; Shigeo Horie; Dorien J M Peters; Vicente E Torres
Journal:  Nat Rev Dis Primers       Date:  2018-12-06       Impact factor: 52.329

4.  Biliary Tract and Liver Complications in Polycystic Kidney Disease.

Authors:  Parminder K Judge; Charlie H S Harper; Benjamin C Storey; Richard Haynes; Martin J Wilcock; Natalie Staplin; Raph Goldacre; Colin Baigent; Jane Collier; Michael Goldacre; Martin J Landray; Christopher G Winearls; William G Herrington
Journal:  J Am Soc Nephrol       Date:  2017-05-02       Impact factor: 10.121

5.  Recurrent Cholangitis in a Patient with Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Caroli's Disease.

Authors:  Eiko Hasegawa; Naoki Sawa; Junichi Hoshino; Tatsuya Suwabe; Noriko Hayami; Masayuki Yamanouchi; Akinari Sekine; Rikako Hiramatsu; Aya Imafuku; Masahiro Kawada; Yoshifumi Ubara; Tsunao Imamura; Kenmei Takaichi
Journal:  Intern Med       Date:  2016-10-15       Impact factor: 1.271

6.  Bacterial Cholangitis in Autosomal Dominant Polycystic Kidney and Liver Disease.

Authors:  William P Martin; Lisa E Vaughan; Kotaro Yoshida; Naoki Takahashi; Marie E Edwards; Andrew Metzger; Sarah R Senum; Tetyana V Masyuk; Nicholas F LaRusso; Matthew D Griffin; Ziad El-Zoghby; Peter C Harris; Walter K Kremers; David M Nagorney; Patrick S Kamath; Vicente E Torres; Marie C Hogan
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2019-05-27

7.  Hepatointestinal complications in polycystic kidney disease.

Authors:  Shih-Ting Huang; Ya-Wen Chuang; Tung-Min Yu; Cheng-Li Lin; Long-Bin Jeng
Journal:  Oncotarget       Date:  2017-09-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.